Latest News

FDA Approves Akeso’s PD-1 Monoclonal Antibody for Recurrent or Metastatic Non-Keratinizing Nasopharyngeal Carcinoma
FDA Approves Akeso’s PD-1 Monoclonal Antibody for Recurrent or Metastatic Non-Keratinizing Nasopharyngeal Carcinoma

April 25th 2025

Approval of penpulimab-kcqx marks the company’s US regulatory debut and introduces a new immunotherapy option for advanced nasopharyngeal carcinoma.

Stock.adobe.com
Ferring Sees Financial Success with Bladder Cancer Gene Therapy, Announces Plans for New Manufacturing Facility

April 25th 2025

Bill Coyle
Predicting and Planning for Tariff Impacts: Q&A with Bill Coyle

April 25th 2025

Marcel Botha
The Risks and Opportunities of Tariffs: Q&A with Marcel Botha

April 25th 2025

Arda Ural
How the Tariffs Expose Vulnerabilities in the Pharma Pipeline

April 25th 2025

The 2025 Pharmaceutical Executive APEX Awards

You deserve the spotlight. Your work educates, informs, and empowers decisions that save lives—and now it’s time for the industry to take notice.

You deserve the spotlight. Your work educates, informs, and empowers decisions that save lives — and now it’s time for the industry to take notice.

Conference Coverage

View All
JPM25: Oncology Outlook for 2025
JPM25: Oncology Outlook for 2025

January 20th 2025

Stock.adobe.com
NVIDIA Announces Pharma Partnerships to Expand AI

January 15th 2025

Stock.adobe.com
Moderna Details Product Pipeline and Finances Ahead of JP Morgan Presentation

January 14th 2025

Stock.adobe.com
Biohaven Details Pipeline Update At JP Morgan Conference

January 14th 2025

Latest Videos
Podcasts
Peter Ax, UpScriptHealth
Jennifer Butler

All News